Zoetis Inc (NYSE:ZTS), where 3,559,860 shares were sold off, resulting in an 86.07% decrease in shares and a -1.33% impact on the portfolio. The stock traded at an average price of $184.26 during ...

Labcorp Holdings Inc (NYSE:LH), with all 1,381,908 shares liquidated, causing a -0.6% impact on the portfolio. Zoetis Inc (NYSE:ZTS), where 3,559,860 shares were sold off, resulting in an 86.07% ...

AIM Vaccine Co., Ltd., a leading supplier of rabies vaccines, has submitted a pre-application for marketing its innovative serum-free rabies vaccine, which has demonstrated excellent safety and ...

A 61-year-old woman reportedly suffered paralysis after being administered rabies vaccine at the Government Medical College Hospital (MCH), Alappuzha. Shanthamma, 61, of Thakazhi in Kuttanad ...

Zoetis is a global leader in animal health, specializing in products for both companion animals and livestock. The company offers a diverse range of products, which includes medicines, vaccines ...

Nov 4 (Reuters) - Zoetis (ZTS.N), opens new tab raised its annual profit and revenue forecasts on Monday on strong demand for its medicines and vaccines for animals. Shares of the animal ...

Significant gaps in post-bite care were noted, as 20.5% of dog-bite victims received no anti-rabies vaccination (ARV), and among those who did receive ARV, nearly half of the 1,253 people who ...

Zoetis is also staying laser-focused on smart moves. By offloading its medicated feed additive portfolio, the company is freeing up resources to double down on its high-growth areas like vaccines ...

The financial sector has outperformed tech stocks, according to Vanguard. Financial stocks surged after the election. 2024 isn't quite in the books, but it's already been a banner year for stocks.

(KFSN) -- Health officials are investigating a rabies exposure in a Fresno County ... with immunoglobulin, with vaccines is 100% effective in preventing the symptoms," said Dr. Sivasubramanian.

Kennedy, Jr. to lead the U.S. Department of Health and Human Services has thrust the debate over vaccine efficacy into the national spotlight. The facts about vaccine safety have never been more ...